Researchers at Australia’s QIMR Berghofer Medical Research Institute have identified over 250 genes linked to moles and melanoma. Published in Nature Communications, the study uses genetic data from 85,000 people to develop a polygenic risk score, offering a new way to predict melanoma risk beyond traditional sun exposure and skin pigmentation factors.
How will genetic risk scores change melanoma screening?
The development of a polygenic risk score marks a shift toward precision medicine in dermatology. While doctors currently assess melanoma risk based on visible traits like skin color and sun damage, this new genetic tool allows for a deeper look at biological susceptibility.
According to the QIMR Berghofer study, researchers uncovered 24 new genetic regions linked to mole counts—a five-fold increase over previous findings. This data suggests that a person’s genetic makeup can dictate their “moliness,” which is a significant indicator of cancer risk. Since approximately one-third of melanomas develop from existing moles, identifying high-risk individuals through DNA could allow for earlier, more frequent clinical monitoring.
Future clinical trends likely involve integrating these genetic scores into standard dermatological check-ups. Instead of a one-size-fits-all approach to sun safety, healthcare providers may soon use genetic profiles to determine which patients require aggressive preventative measures.
Pro Tip: Skin Monitoring
While genetic research advances, dermatologists recommend the “ABCDE” method to monitor moles: Asymmetry, Border irregularity, Color changes, Diameter increase, and Evolving shape. If a mole changes in any of these ways, consult a professional immediately.
Can the SIKE1 gene lead to new cancer treatments?
The identification of the SIKE1 gene provides a potential new target for immunotherapy. In the study, researchers noted that while moles and melanomas both originate from pigment-producing melanocytes, their growth patterns differ fundamentally.
Moles typically stop growing once they form a cluster, but melanoma cells continue to proliferate aggressively. Associate Professor Matthew Law, the study’s corresponding author, stated that studying moles helps scientists understand the biology of melanoma to find new ways of controlling the disease.
By targeting specific pathways—such as the immune responses that fail to control cell growth—future treatments may move away from broad-spectrum chemotherapy toward highly specific molecular interventions. If SIKE1 can be successfully manipulated to restore immune control, it could represent a significant advancement in treating the deadliest form of skin cancer.
Why does mole count matter for skin cancer risk?
The connection between mole density and melanoma is more than just visual. The research highlights that “moliness” is strongly influenced by specific genetic pathways, including those involved in harmful cell proliferation seen in other types of cancer.
The study distinguishes between two primary risk categories:
- Environmental Risks: Well-known factors such as UV exposure and skin pigmentation.
- Genetic Risks: Complex biological pathways, including immune system failures and cell growth regulation, that operate independently of sun exposure.
Understanding these genetic drivers helps explain why some individuals develop melanoma despite low sun exposure. The ability to identify these underlying drivers allows the medical community to address the biological “engine” of the cancer rather than just the external triggers.
Frequently Asked Questions
Do all moles turn into melanoma?
No. While about one-third of melanomas develop from existing moles, most moles remain benign clusters of cells that do not become cancerous.
How does genetic testing help with skin cancer?
Genetic testing can identify specific risk markers, like the SIKE1 gene or high polygenic risk scores, helping doctors predict who is at a higher biological risk before symptoms appear.
Is sun exposure the only cause of melanoma?
No. While sun exposure is a major risk factor, this study confirms that genetic pathways and immune system responses also play critical roles in how melanoma develops.
Want to stay updated on the latest medical breakthroughs? Subscribe to our newsletter or share this article with your network to spread awareness about skin cancer prevention.
